CLOs on the Move

Utah Medical Products

www.utahmed.com

 
Utah Medical Products, Inc. is a Midvale, UT-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

QualCare Inc.

QualCare, Inc., one of the region`s leading providers of health care coverage, provides the public and private marketplace with a higher-quality, lower-cost alternative to commercial insurance companies. QualCare`s network covers over 100 acute, specialty and rehabilitation hospitals, as well as over 31,000 physicians and other ancillary providers across New Jersey, New York and Pennsylvania. Founded in 1991 from a consortium of hospital systems, QualCare has experienced dramatic growth over the past two decades. Currently, 16 of New Jersey`s largest and most successful hospitals own and serve on QualCare`s Board of Directors. QualCare services over 900,000 members, with a clientele that spans health systems, unions, local governments, school boards, small to large businesses and some of New Jersey`s largest corporations. With rate increases that are consistently below industry standards and unparalleled service satisfaction, QualCare is well positioned to succeed in the changing healthcare industry.

Axminster Medical Group

During the past 40 years, AXMINSTER Medical Group has earned the reputation as being a provider of distinctive care and service. The physicians and nurses at AXMINSTER Medical Group believe in a team approach to offering patient care. They work

Whisper Hearing Center

Whisper Hearing Center is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Behavioral Medical Research of Staten Island, PC

Behavioral Medical Research of Staten Island, PC is a Staten Island, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dyax Corp.

Dyax Corp. (Dyax) is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications.